These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 19747133)

  • 1. Design strategies of novel NNRTIs to overcome drug resistance.
    Zhan P; Liu X; Li Z; Pannecouque C; De Clercq E
    Curr Med Chem; 2009; 16(29):3903-17. PubMed ID: 19747133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel broad-spectrum thiourea non-nucleoside inhibitors for the prevention of mucosal HIV transmission.
    D'Cruz OJ; Uckun FM
    Curr HIV Res; 2006 Jul; 4(3):329-45. PubMed ID: 16842085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structures of 8-Cl and 9-Cl TIBO complexed with wild-type HIV-1 RT and 8-Cl TIBO complexed with the Tyr181Cys HIV-1 RT drug-resistant mutant.
    Das K; Ding J; Hsiou Y; Clark AD; Moereels H; Koymans L; Andries K; Pauwels R; Janssen PA; Boyer PL; Clark P; Smith RH; Kroeger Smith MB; Michejda CJ; Hughes SH; Arnold E
    J Mol Biol; 1996 Dec; 264(5):1085-100. PubMed ID: 9000632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The search for potent, small molecule NNRTIs: A review.
    Prajapati DG; Ramajayam R; Yadav MR; Giridhar R
    Bioorg Med Chem; 2009 Aug; 17(16):5744-62. PubMed ID: 19632850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel tight binding PETT, HEPT and DABO-based non-nucleoside inhibitors of HIV-1 reverse transcriptase.
    D'Cruz OJ; Uckun FM
    J Enzyme Inhib Med Chem; 2006 Aug; 21(4):329-50. PubMed ID: 17059165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 NNRTIs: structural diversity, pharmacophore similarity, and implications for drug design.
    Zhan P; Chen X; Li D; Fang Z; De Clercq E; Liu X
    Med Res Rev; 2013 Jun; 33 Suppl 1():E1-72. PubMed ID: 21523792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of HIV-2 reverse transcriptase at 2.35-A resolution and the mechanism of resistance to non-nucleoside inhibitors.
    Ren J; Bird LE; Chamberlain PP; Stewart-Jones GB; Stuart DI; Stammers DK
    Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14410-5. PubMed ID: 12386343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The phenylmethylthiazolylthiourea nonnucleoside reverse transcriptase (RT) inhibitor MSK-076 selects for a resistance mutation in the active site of human immunodeficiency virus type 2 RT.
    Auwerx J; Stevens M; Van Rompay AR; Bird LE; Ren J; De Clercq E; Oberg B; Stammers DK; Karlsson A; Balzarini J
    J Virol; 2004 Jul; 78(14):7427-37. PubMed ID: 15220416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The structure of FIV reverse transcriptase and its implications for non-nucleoside inhibitor resistance.
    Galilee M; Alian A
    PLoS Pathog; 2018 Jan; 14(1):e1006849. PubMed ID: 29364950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of the non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1.
    Balzarini J
    Curr Top Med Chem; 2004; 4(9):921-44. PubMed ID: 15134549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Looking for an active conformation of the future HIV type-1 non-nucleoside reverse transcriptase inhibitors.
    La Regina G; Coluccia A; Silvestri R
    Antivir Chem Chemother; 2010 Aug; 20(6):213-37. PubMed ID: 20710063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 1.
    Hopkins AL; Ren J; Milton J; Hazen RJ; Chan JH; Stuart DI; Stammers DK
    J Med Chem; 2004 Nov; 47(24):5912-22. PubMed ID: 15537346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 RT nonnucleoside inhibitors and their interaction with RT for antiviral drug development.
    Zhou Z; Lin X; Madura JD
    Infect Disord Drug Targets; 2006 Dec; 6(4):391-413. PubMed ID: 17168804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of feline immunodeficiency virus/human immunodeficiency virus type 1 reverse transcriptase chimeras to non-nucleoside RT inhibitors.
    Auwerx J; Esnouf R; De Clercq E; Balzarini J
    Mol Pharmacol; 2004 Jan; 65(1):244-51. PubMed ID: 14722257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Lys103Asn mutation of HIV-1 RT: a novel mechanism of drug resistance.
    Hsiou Y; Ding J; Das K; Clark AD; Boyer PL; Lewi P; Janssen PA; Kleim JP; Rösner M; Hughes SH; Arnold E
    J Mol Biol; 2001 Jun; 309(2):437-45. PubMed ID: 11371163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of "dual-site"-binding diarylpyrimidines targeting both NNIBP and the NNRTI adjacent site of the HIV-1 reverse transcriptase.
    Feng D; Zuo X; Zhao F; Lin H; Dai J; Sun Y; Clercq E; Pannecouque C; Kang D; Liu X; Zhan P
    Eur J Med Chem; 2023 Feb; 247():115045. PubMed ID: 36577216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystallography and the design of anti-AIDS drugs: conformational flexibility and positional adaptability are important in the design of non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Das K; Lewi PJ; Hughes SH; Arnold E
    Prog Biophys Mol Biol; 2005 Jun; 88(2):209-31. PubMed ID: 15572156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in DAPYs and related analogues as HIV-1 NNRTIs.
    Chen X; Zhan P; Li D; De Clercq E; Liu X
    Curr Med Chem; 2011; 18(3):359-76. PubMed ID: 21143120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance-associated mutations and polymorphisms in NNRTI-naïve HIV-infected patients.
    Clevenbergh P; Cua E; Dam E; Durant J; Schmit JC; Boulme R; Cottalorda J; Beyou A; Schapiro JM; Clavel F; Dellamonica P
    HIV Clin Trials; 2002; 3(1):36-44. PubMed ID: 11819184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for potent and broad inhibition of HIV-1 RT by thiophene[3,2-
    Yang Y; Kang D; Nguyen LA; Smithline ZB; Pannecouque C; Zhan P; Liu X; Steitz TA
    Elife; 2018 Jul; 7():. PubMed ID: 30044217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.